X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Increased RET Activity Coupled with a Reduction in the RET Gene Dosage Causes Intestinal Aganglionosis in Mice.

Mitsumasa Okamoto | Toshihiro Uesaka | Keisuke Ito | Hideki Enomoto
eNeuro | 2021

Mutations of the gene encoding the RET tyrosine kinase causes Hirschsprung's disease (HSCR) and medullary thyroid carcinoma (MTC). Current consensus holds that HSCR and MTC are induced by inactivating and activating RET mutations, respectively. However, it remains unknown whether activating mutations in the RET gene have adverse effects on ENS development in vivo We addressed this issue by examining mice engineered to express RET51(C618F), an activating mutation identified in MTC patients. Although Ret51(C618F)/51(C618F) mice displayed hyperganglionosis of the ENS, Ret51(C618F)/- mice exhibited severe intestinal aganglionosis because of premature neuronal differentiation. Reduced levels of glial cell-derived neurotrophic factor (GDNF), a RET-activating neurotrophic factor, ameliorated the ENS phenotype of Ret51(C618F)/- mice, demonstrating that GDNF-mediated activation of RET51(C618F) is responsible for severe aganglionic phenotype. The RET51(C618F) allele showed genetic interaction with Ednrb gene, one of modifier genes for HSCR. These data reveal that proliferation and differentiation of ENS precursors are exquisitely controlled by both the activation levels and total dose of RET. Increased RET activity coupled with a decreased gene dosage can cause intestinal aganglionosis, a finding that provides novel insight into HSCR pathogenesis.

Pubmed ID: 33958373 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Donkey Anti-Goat IgG(H+L) Antibody, CF640R Conjugated (antibody)

RRID:AB_10853145

This unknown targets Donkey Goat IgG(H+L) CF640R

View all literature mentions

Donkey Anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Antibody, CF568 Conjugated (antibody)

RRID:AB_10557118

This unknown targets Donkey Rabbit IgG (H+L) Highly Cross-Adsorbed CF568

View all literature mentions

Donkey Anti-Goat IgG (H+L) Highly Cross-Adsorbed Antibody, CF568 Conjugated (antibody)

RRID:AB_10559672

This unknown targets Donkey Goat IgG (H+L) Highly Cross-Adsorbed CF568

View all literature mentions

Donkey Anti-Chicken IgY (IgG) (H+L) Antibody, CF488A Conjugated (antibody)

RRID:AB_10854387

This unknown targets Donkey Chicken IgY (IgG) (H+L) CF488A

View all literature mentions

Donkey Anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Antibody, CF488A Conjugated (antibody)

RRID:AB_10559669

This unknown targets Donkey Rabbit IgG (H+L) Highly Cross-Adsorbed CF488A

View all literature mentions

Anti-Green Fluorescent Protein Antibody (antibody)

RRID:AB_10000240

This polyclonal targets Green Fluorescent Protein (GFP)

View all literature mentions

Sox-10 (N-20) (antibody)

RRID:AB_2195374

This unknown targets Raised against peptide mapping to N-terminus of sox-10 of human origin

View all literature mentions

Phox2b (antibody)

RRID:AB_2313690

This unknown targets

View all literature mentions